Singlera Genomics

ActiveOn the In-vitro diagnostics Radar · not rankedNot open to Backers

In-vitro diagnostics · China

Develops DNA methylation and sequencing-based tests for early cancer detection and prenatal screening, with labs in China and the United States.

Healthtech›In-vitro diagnostics singlera.com

HQChina

Last roundStrategic financing · Jul 2024

Why Singlera Genomics is not ranked yet

How the Radar works →

The Radar lists every known eligible company, sorted by date of last round, with no AI judgement. Singlera Genomics enters the ranking once its public data is sufficient for the AI to estimate it. Next In-vitro diagnostics worldwide edition: 12 Apr 2027.

Funding history

Date	Round	Amount	Type	Investors
Jul 2024	Strategic financing	—	Equity	Yangzhou Guojin, Longchuan Holding, other Yangzhou municipal state-owned funds

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
In-vitro diagnostics · worldwide	Radar	—	Edition 0 · Oct 2026	12 Apr 2027

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Singlera Genomics as a PDF. It must answer at least one of these four questions, and stick to them:

ValuationWhat is Singlera Genomics worth?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Who should it acquireAcquisition targets, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Not open to BackersCompanies based in mainland China are ranked like any other startup, but Uback does not open pools on them: capital controls and offshore (VIE) structures make minority deals impractical for our Backers.

You can still declare an interest in this segment:

Or back in-vitro diagnostics worldwide

Do you run Singlera Genomics?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in in-vitro diagnostics

Full in-vitro diagnostics ranking →

Function Health#1United StatesUnicorn Delfi Diagnostics#2United StatesUnicorn Everlywell#3United StatesHundreds of M$LetsGetChecked#4IrelandHundreds of M$

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.